Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 28, 2022, Enveric Biosciences, Inc. (the "Company") held its 2022 annual meeting of stockholders (the "Annual Meeting"). A total of 856,447 shares of the Company's common stock were present in person or represented by proxy at the Annual Meeting, which represented 41.2% of the outstanding shares of common stock entitled to vote at the Annual Meeting and constituted a quorum for the transaction of business. Holders of the Company's common stock were entitled to one vote per share of common stock held as of the close of business on September 14, 2022, the record date for the Annual Meeting. The matters submitted for a vote and the related results are set forth below.



  1. Election of seven directors, to serve until the Company's 2023 annual meeting
     of stockholders or until their successors are duly elected and qualified.



           Nominee                  For        Withheld      Broker Non-Votes
George Kegler                      138,269       109,803           608,375
Douglas Lind, M.D.                 228,007       20,065            608,375
Bevin O'Neil                       226,712       21,360            608,375
Frank Pasqualone                   226,764       21,308            608,375
Marcus Schabacker, M.D., Ph.D.     139,581       108,491           608,375
Joseph Tucker, Ph.D.               228,825       19,247            608,375
Michael D. Webb                    226,729       21,343            608,375



  2. Non-binding advisory vote to approve the compensation of the Company's named
     executive officers.



  For       Against      Abstain      Broker Non-Votes
178,176       68,125        1,771           608,375



  3. Ratification of the selection and appointment of Marcum LLP as the Company's
     independent registered public accounting firm for the fiscal year ending
     December 31, 2022



  For       Against      Abstain
826,728       27,656        2,063

For more information about the foregoing proposals, see the Company's definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on September 23, 2022, the relevant portions of which are incorporated herein by reference. The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

© Edgar Online, source Glimpses